Inhalation Products
In inhalation drug development, SkyePharma offers:
Cost effective devices
Proprietary formulation technologies
SkyePharma uses a range of novel excipients in its formulation technologies to optimise dose-to-dose repeatability; a major hurdle for regulatory approval of inhalation products.
Copyright 2008, SkyePharma. All Rights Reserved.
SkyePharma PLC is a public limited company registered in England and Wales, registration number 0107582.
Registered office: 105 Piccadilly, London, W1J 7NJ, United Kingdom
For enquiries, please
contact us.